Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Pregnancy Prevention: early-phase trial registry

2 of 5 indexed Pregnancy Prevention trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Pregnancy Prevention: 5 US clinical trials tracked, 2 recruiting.

Pregnancy Prevention is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is InnovaGyn, running 2 of these trials.

Enrollment posture brief

Registry condition pregnancy-prevention

OPEN 2 | RECR 40% | LATE 1 | EARLY 3 | RANK #3391 | SPON 2

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Pregnancy Prevention (this)40%
Open-enrollment share among volume-matched conditions near Pregnancy Prevention

Pregnancy Prevention lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pregnancy Prevention on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pregnancy Prevention is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Pregnancy Prevention research.

    InnovaGyn accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Pregnancy Prevention trials plan to enrol fewer than 100 people.

    Median target enrolment is 22 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Pregnancy Prevention research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 23Phase 31

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 3 1

Top Sponsors

InnovaGyn 2 trials
Ashley Philliber 1 trials
Jack Stevens 1 trials

Named interventions

Most-linked intervention names on Pregnancy Prevention records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

DR-103 Drug
1 trials
SkillTalk Behavioral
1 trials
Healthy Adolescent Transitions (HAT) program Behavioral
1 trials
Levonorgestrel 1.5mg Drug
1 trials
calcium carbonate 750 milligram Other
1 trials
Meloxicam 15 milligram Drug
1 trials
Levonorgestrel 0.15 milligram Drug
1 trials
Meloxicam 15 mg Drug
1 trials

US sites by state

Facility locations filed on Pregnancy Prevention trials. A trial with sites in several states counts in each.

North Carolina 2 trials
Ohio 1 trials
New York 1 trials
Florida 1 trials
Colorado 1 trials
California 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pregnancy Prevention page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Pregnancy Prevention trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • InnovaGyn sponsors the most Pregnancy Prevention trials on record, review their full trial history before evaluating a specific study. See InnovaGyn's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pregnancy Prevention condition card totals 5 registered trials; most-linked intervention DR-103; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.